New research suggests that asymptomatic patients with significant risk factors for cardiovascular disease may also need to ...

There is a consensus emerging that surgery is most appropriate for people with severe obesity for whom lifestyle ...

Although rheumatologists consider chimeric antigen receptor T-cell therapy “potentially transformative,” nearly 70% remain ...

Lack of communication about risk and urgency delayed a search for a man who was later found dead in a desert gully, a coroner ...

As the world marks Mental Wellness Month in January, it is high time Ghana confronted mental health honestly. Not through ...

Medicines are becoming a major concern in the UAE. Officials are now reviewing how drug prices are set. This review aims to ...

Your sleep data is screaming long before you feel exhausted, and three red flag metrics consistently predict trouble. I focus ...

By Milliam MurigiAs the burden of non-communicable diseases (NCDs) continues to rise across Africa, gaps in locally driven research and evidence-based service delivery remain a major barrier to ...

The corticosteroids market is driven by rising chronic diseases like asthma and COPD and innovations in drug delivery systems, enhancing treatment adherence. However, prolonged usage safety concerns ...

Healthcare professionals must reject flawed racial generalisations, writes Jasmeen Kanwal Institutional racism in healthcare has received increased coverage in recent years, including in The BMJ ’s ...

Background/aims Up-to-date, stratified estimates of the number of individuals affected by glaucoma in the UK are lacking.

The panel discussion, “Innovations in Breast Cancer Treatment,” examined the challenge of maintaining or increasing access to care as breast cancer treatment becomes more stratified through biomarker ...